A MULTIPLE SIRNA-BASED ANTI-HIV/SHIV MICROBICIDE SHOWS PROTECTION IN BOTH IN VITRO AND IN VIVO MODELS.



Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda

Abstract Background HIV infection increases the risk of placental malaria, which is associated with poor maternal and infant outcomes.Recommendations in Uganda are for HIV-infected pregnant women to receive daily trimethoprim-sulphamethoxazole (TS) and HIV-uninfected women to receive intermittent sulphadoxine-pyrimethamine (SP).TS decreases the ris

read more